False Positive Reactions
Showing 1 - 25 of >10,000
Healthy, Irritation/Irritant, Reactions Adverse Trial (NS Solution, Normal Saline, SLS)
Completed
- Healthy
- +2 more
- NS Solution
- +2 more
- (no location specified)
Nov 1, 2023
Procedural Sedation, Emergence Delirium Trial in Youngstown (Positive Imagery Therapy)
Recruiting
- Procedural Sedation
- Emergence Delirium
- Positive Imagery Therapy
-
Youngstown, OhioMercy Health St Elizabeth Youngstown
Nov 12, 2021
Eczema, Allergic Contact Eczema Nos Trial in Belgium, France (Blood sample, Skin biopsies, ROAT test)
Recruiting
- Eczema
- Allergic Contact Eczema Nos
- Blood sample
- +2 more
-
Bruxelles, Belgium
- +4 more
Nov 6, 2023
IgE-mediated Allergies Among Type 1 Diabetes Mellitus Children,
Completed
- Diabetic Children
- skin prick test
-
Mansoura, None Selected, EgyptMansoura University Children Hospital
Oct 26, 2022
Abbreviated Magnetic Resonance Imaging asScreening Tool for
Recruiting
- Hepatocellular Carcinoma
- MRI
-
Chandigarh, Punjab, IndiaPost Graduate Institute of Medical Education and Research
Feb 6, 2023
Antiphospholipid Syndrome, Anticoagulant Drugs Trial in Clermont-Ferrand (Lupus anticoagulant testing)
Recruiting
- Antiphospholipid Syndrome
- Anticoagulant Drugs
- Lupus anticoagulant testing
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 13, 2022
FALSE POSITIVE FINDINGS IN BREAST CANCER TOMOSYNTHESIS
Completed
- Breast Cancer Screening
-
Avellino, Av, ItalyGraziella Di Grezia
Feb 5, 2020
Brain Metastases Trial in Seoul (BT-M01)
Recruiting
- Brain Metastases
- BT-M01
-
Seoul, Song-pa Gu, Korea, Republic ofAsan Medical Center
Oct 6, 2022
Breast Cancer, Breast Tumors, Breast Cancer Female Trial in United States (contrast-enhanced mammography)
Recruiting
- Breast Cancer
- +3 more
- contrast-enhanced mammography
-
Bethel Park, Pennsylvania
- +4 more
Oct 23, 2023
Promoting Informed Choice for Breast Cancer Screening: A
Recruiting
- Breast Cancer
- REDS survey
-
Aurora, Colorado
- +1 more
Apr 27, 2023
Newly Diagnosed Multiple Myeloma Trial in Austria, Germany (Elotuzumab, Carfilzomib, Lenalidomide)
Active, not recruiting
- Newly Diagnosed Multiple Myeloma
- Elotuzumab
- +4 more
-
Krems, Lower Austria, Austria
- +55 more
Jan 4, 2022
VAlidation of a Lower Cost aneUploidy scrEen
Completed
- Down Syndrome
- +2 more
- SmartNIPT
-
Los Angeles, California
- +15 more
Sep 19, 2022
Thoracic Outlet Syndrome Trial in Angers (Transcutaneous Oximetry, Photopletysmography, Questionnaires of Quality of Life (QoL))
Active, not recruiting
- Thoracic Outlet Syndrome
- Transcutaneous Oximetry
- +2 more
-
Angers, FranceUH Angers
Sep 26, 2022
Novel Algorithm System for Polypharmacy Patient Medication
Completed
- Polypharmacy Patients
- Multi-drug analysis of polypharmacy treatment
-
Jerusalem, IsraelHadassah Ein Kerem
Oct 18, 2022
Esophageal Tumors, Gastric Tumors Malignant, Breast Cancer Trial in Stockholm ([68Ga]Ga-ABY-025 PET, Biopsy and analysis of HER2
Recruiting
- Esophageal Neoplasms
- +3 more
- [68Ga]Ga-ABY-025 PET
- Biopsy and analysis of HER2 expression
-
Stockholm, SwedenDepartment of Radiation Physics and Nuclear Medicine, Karolinska
Nov 25, 2022
Congenital Cataract Trial (Neocam)
Not yet recruiting
- Congenital Cataract
- Neocam
- (no location specified)
Mar 30, 2022
Aneuploidy Trial in Naples (NIPT)
Recruiting
- Aneuploidy
- NIPT
-
Naples, ItalyUniversity Federico II
Apr 2, 2023
AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in Diagnosis
Completed
- COVID19
- Diagnostic Software as Medical Device
-
Tampa, FloridaUniversity of South Florida
May 4, 2022
To EstablishMolecular Typing System for Early Diagnosis of Lung
Recruiting
- Lung Cancer
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Jun 20, 2022
Drug Allergy Trial in Istanbul (diagnostics)
Completed
- Drug Allergy
- diagnostics
-
Istanbul, TurkeyIstanbul University-Cerrahpasa
Jan 20, 2023
Breast Cancer, HER2-positive Breast Cancer Trial in Zhengzhou (Albumin paclitaxel+trastuzumab+pyrrolitinib,
Active, not recruiting
- Breast Cancer
- HER2-positive Breast Cancer
- Albumin paclitaxel+trastuzumab+pyrrolitinib
- Docetaxel+Carboplatin+trastuzumab+Parstuzumab
-
Zhengzhou, Henan, ChinaHenan cancer hospital
Jun 23, 2023
Bladder Cancer Trial in Roskilde (Urine test)
Recruiting
- Bladder Cancer
-
Roskilde, DenmarkZealand University Hospital
Oct 5, 2022
Commercial Assay for the Detection of Neuronal Antibodies
Completed
- Paraneoplastic Neurological Syndrome
- Autoimmune Encephalitis
- Indirect immunofluorescence assay on tissue slides and cell-based assays with CSF and/or sera
-
Bron, France
- +1 more
Mar 13, 2023
Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))
Completed
- Cancer of Kidney
- +6 more
- 124-Iodine-cG250 (124I-cG250)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
Paclitaxel-induced Polyneuropathy in Breast Cancer: Early
Not yet recruiting
- Breast Neoplasms
- +7 more
- Garmin smartwatch
- +2 more
-
Solna, Stockholm, SwedenKarolinska University Hospital
Sep 18, 2023